Positive start likely amid encouraging cues from Asian peers Positive start likely amid encouraging cues from Asian peers DSIJ Intelligence-3 / Tuesday, July 23, 2019 0 852 Article rating: 5.0 The outlook for the day is a flat to positive start on the back of cheerful cues from the Asian peers. At the time of writing, the SGX Nifty was up by 14 points at 11,353. Read more
FPI and equity market: A bizarre relation FPI and equity market: A bizarre relation DSIJ Intelligence / Monday, July 22, 2019 0 1387 Article rating: 5.0 Out of last nine trading session, FIIs remained net seller in all of those sessions. The major indices are down by more than 4 per cent. Read on to find if FIIs selling is related to such fall. Read more
Quarterly results to watch out on July 23 Quarterly results to watch out on July 23 DSIJ Intelligence / Monday, July 22, 2019 0 1308 Article rating: 4.2 The following stocks would be in focus during Tuesday’s trading session in light of their results announcement: CRISIL, DCM Shriram, Hindustan Unilever, L&T and Praj Industries. Read more
BHEL rises on bagging order worth Rs. 486 crore BHEL rises on bagging order worth Rs. 486 crore DSIJ Intelligence / Monday, July 22, 2019 0 1256 Article rating: 3.8 Bharat Heavy Electricals (BHEL) has secured an order worth Rs. 486 crore for erection work of reactor side equipment of 2x1000 MWe (Units 3&4) Kudankulam Nuclear Power Project in Tamil Nadu which is being set up under foreign co-operation (Russia). Read more
Alembic Pharma gets approval for neuropathic pain capsule Alembic Pharma gets approval for neuropathic pain capsule DSIJ Intelligence / Monday, July 22, 2019 0 3504 Article rating: 4.0 Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for the company’s Abbreviated New Drug Application (ANDA) Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. Read more